Mitzi Chang is a partner in Goodwin’s Technology & Life Sciences group and serves as co-chair of its Digital Currency & Blockchain Technology practice. She focuses on corporate and securities law, representing public and private companies, venture capital and private equity firms and investment banks in capital markets transactions, mergers and acquisitions, venture capital financings, SEC reporting and other general corporate and securities matters. Ms. Chang advises companies through every stage of the corporate life cycle – from initial financing through successful initial public offering or acquisition. Ms. Chang also advises blockchain and digital currency companies and venture funds with respect to digital token sales and related securities law and regulatory matters. Prior to joining Goodwin, Ms. Chang spent three years as in-house legal counsel at a Nasdaq listed public technology company in San Francisco.

Ms. Chang currently serves on the firm’s Committee on Racial and Ethnic Diversity and on the hiring committee for Goodwin’s San Francisco office.

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

Work for clients:

Public offerings

  • aTyr Pharma, Inc. in its $75 million initial public offering, $35 million at-the-market offering and $45.8 million PIPE transaction 
  • Fate Therapeutics, Inc. in its $40 million initial public offering, $30 million follow-on public offering, $8 million private placement with Juno Therapeutics and PIPE transactions totaling $67 million
  • Imperva in its $90 million initial public offering
  • Limelight Networks, Inc. in a $60 million follow-on secondary offering
  • Capstone Turbine Corporation in a $25 million at-the-market offering
  • Various underwriters in connection with a $43 million follow-on offering for Regulus Therapeutics
  • Anthera Pharmaceuticals, Inc. in its $42 million initial public offering and $31.5 million PIPE transaction
  • A biopharmaceutical company in its $9 million follow-on public offering
  • A nanotechnology holding company in its $8 million registered direct offering

Mergers and acquisitions

  • Teva Pharmaceuticals Industries, Ltd. in its $3.2 billion acquisition of Auspex Pharmaceuticals, Inc.
  • ECG Management Consultants, Inc. in its recapitalization by Gryphon Investors
  • Spotlite, Inc. in its sale to Rally Health
  • Onyx Pharmaceuticals, Inc. in its $10.4 billion sale to Amgen
  • Courier Corporation in its acquisition of FastPencil, Inc.
  • Location Labs in its sale to AVG Technologies
  • InsightsOne Systems, Inc. in its sale to Apigee Corporation
  • A startup company in a “spin-in” transaction with a publicly traded technology company
  • Companies in acquihire transactions with Facebook, Google, Yahoo!, and Ebay
  • Whiskey Media in its sale transactions with CBS Interactive and BermanBraun
  • NeuroFocus, Inc. in its sale to Nielsen Holdings, N.V.
  • Various acquisitions as in-house counsel for CNET Networks, Inc.*

Financing transactions

  • Greycroft Partners in various growth-equity investments, including Yeahka, a Chinese mobile payment service provider, Performance Horizon Group Limited, a UK SaaS marketing platform, Axios Media, a media company, the RealReal, a luxury resale retailer, and SEMrush, an enterprise software provider
  • e.Ventures in various investments, including NomNomNow, Yeahka, Axios Media, theRealReal, and SEMRush
  • Thomvest Ventures in various investments, including in Apsalar, Avalanche Technology, Netbase and Tactus Technology
  • Franklin Templeton in various investments, including in BondLink and Seriforge
  • Margeta in its Series D and D-1 preferred stock financings
  • IVP in its investment in Woven
  • Ayla Networks in its Series C and Series D preferred stock financing
  • WePay in its $40 million Series D preferred stock financing
  • ThredUp, Inc. in its $81 million Series E preferred stock financing
  • RocketLawyer in its preferred stock financings
  • Industry Ventures in its investment in TheRealReal
  • aTyr Pharma, Inc. in its $76 million Series E preferred stock financing
  • Royalty Pharma in its purchases of royalties in various transactions totaling over $2 billion
  • TA Associates in its investment in Millennium Laboratories, Inc.
  • LLM Capital Partners in its investment in Hybrid Design Associates, LLC
  • Pipeline Angels in over 25 portfolio company investments
  • Various funds and blockchain technology clients in traditional and digital securities offerings

* Denotes experience prior to joining Goodwin.

Professional Activities

Ms. Chang is a member of the American Bar Association, San Francisco Bar Association and the State Bar of California.

Professional Experience

Prior to joining Goodwin, Ms. Chang was a senior counsel at CBS Interactive Inc. (formerly CNET Networks, Inc.), where she advised and supported the company’s Games, Music & Lifestyle and TV Entertainment divisions in their business-related matters as well as the company in its acquisitions, securities-related and other corporate matters. She previously practiced as an associate in the corporate department of the San Francisco office of Latham & Watkins LLP.

Recognition

Ms. Chang was named as a 2018 National Law Journal Cryptocurrency, Blockchain and Fintech Trailblazer.

While attending law school, Ms. Chang was a Notes and Comments Editor for The Tax Lawyer, for which she authored “Reasonableness, First Impression, and the Accuracy-Related Penalty: Neonatology Associates v. Commissioner” (2001).

In The News

MELDUNGEN

ACTUALITÉS

相关新闻

Credentials

WERDEGANG

RÉFÉRENCES

专业资格

Education

J.D., 2002
Georgetown University Law Center
B.A., 1999
University of California, Berkeley

(magna cum laude, Phi Beta Kappa)

Admissions

Bar

California
Get In Touch
German Translation
NOUS CONTACTER
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
Recherche par Pratique
搜寻其他律师